# Infracyanine Green vs Brilliant Blue G in Macular Hole Inverted Flap Surgery: A Swept Source OCT Analysis.

> **NCT03946267** · NA · COMPLETED · sponsor: **Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo** · enrollment: 43 (actual)

## Conditions studied

- Macular Holes

## Interventions

- **DEVICE:** Inverted inner limiting membrane flap technique for large full thickness macular holes

## Key facts

- **NCT ID:** NCT03946267
- **Lead sponsor:** Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-09
- **Primary completion:** 2018-07-31
- **Final completion:** 2018-08-23
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2020-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03946267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03946267, "Infracyanine Green vs Brilliant Blue G in Macular Hole Inverted Flap Surgery: A Swept Source OCT Analysis.". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03946267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
